Clinical Trials Arena April 25, 2024
Welcome to the first of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?” Transactions involving digital assets are becoming an increasing focus for pharmaceutical companies. In this series, life sciences industry M&A veteran and Sterling Technology board advisor John Easton will discuss how these differ from traditional life science deals,...